Methamphetamine (METH) markedly increases dopamine (DA) release in the mesolimbic DA system, which plays an important role in mediating the reinforcing effects of METH. METH-induced DA release results in the formation of reactive oxygen species (ROS), leading to oxidative damage. We have recently reported that ROS are implicated in behavior changes and DA release in the nucleus accumbens (NAc) following cocaine administration. The aim of this study was to evaluate the involvement of ROS in METH-induced locomotor activity, self-administration and enhancement of DA release in the NAc. Systemic administration of a non-specific ROS scavenger, N-tert-butyl-α-phenylnitrone (PBN; 0, 50 and 75 mg/kg, IP) or a superoxide-selective scavenger, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL; 0, 50 and 100 mg/kg, IP), attenuated METH-induced locomotor activity without affecting generalized behavior in METH-naïve rats. PBN and TEMPOL significantly attenuated METH self-administration without affecting food intake. Increased oxidative stress was found in neurons, but not astrocytes, microglia or oligodendrocytes, in the NAc of METH self-administering rats. In addition, TEMPOL significantly decreased METH enhancement of DA release in the NAc. Taken together, these results suggest that enhancement of ROS in the NAc contributes to the reinforcing effect of METH.
INTRODUCTION
Methamphetamine (METH) is a highly potent and addictive psychostimulant, which causes serious psychosocial problems. Methamphetamine use leads to compulsive behaviors, including repetitive taking and seeking of the drug, and a loss of control over intake. Physiologically, METH increases oxidative stress via metabolic activation. The mesocorticolimbic dopamine (DA) system projecting from the ventral tegmental area to the nucleus accumbens (NAc) and prefrontal cortex plays a critical role in the reinforcing effects of METH (Koob 1992; Rose & Grant 2008) .
The reinforcing properties of METH are mediated by an elevation of extracellular DA levels in the dorsal and ventral striatum through METH's interaction with the DA transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) (Volkow et al. 2007) . For example, exposure to METH or amphetamine increases locomotor activity by increasing extracellular DA release in the dorsal and ventral striatum (Frankel et al. 2007; Kuczenski et al. 1991; Miller et al. 2014) . In addition, repeated exposure to METH can cause neurotoxicity via formation of reactive oxygen species (ROS) in DAergic neurons (Sun et al. 2015) . Others have shown that exposure to METH increased † Both authors equally contributed to this work.
malondialdehyde, a product of lipid peroxidation by ROS in brain regions of METH-exposed rats (Horner et al. 2011) and METH users (Fitzmaurice et al. 2006) . Methamphetamine significantly decreases glutathione, an antioxidant, in the NAc and prefrontal cortex of chronically treated animals (Bu et al. 2013) . Recently, it has been shown that a non-specific ROS scavenger, a-phenyl-N-tert-butyl nitrone (PBN), protected against METH-induced neurotoxicity (ROS formation) and against self-injurious behaviors caused by METH in mice (Kita et al. 2000) . The superoxide-specific scavenger 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL) has also been used for preventing mitochondrial oxidative damage and METHinduced behavioral sensitization in rats (Shiba et al. 2011) . Furthermore, we and others have implicated ROS in the development of behavioral sensitization following repeated contingent and non-contingent administration of psychostimulants, such as cocaine (Jang et al. 2015; Numa et al. 2008) . However, the role of ROS in the reinforcing effects of METH has not been investigated.
We hypothesized that increased ROS following chronic METH exposure is involved in reward signaling in the mesolimbic DAergic pathway, which might contribute to the reinforcing effects of METH. To evaluate this hypothesis, we investigated the effects of the non-specific ROS scavenger PBN, and the superoxide dismutase (SOD) mimetic TEMPOL on METH-induced locomotor activity using the open-field paradigm, METH self-administration and METH-induced DA release in the NAc using fast scan cyclic voltammetry (FSCV). In addition, using immunohistochemistry, we characterized the cellular source of ROS in the NAc of rats self-administering METH.
MATERIALS AND METHODS

Animal subjects
Male Sprague-Dawley rats (Daehan Animal, Seoul, Korea; Charles Laboratory, CA, USA) weighing 270-350 g were used in the locomotor activity and METH selfadministration experiments, and male Wistar rats weighing 250-320 g from our breeding colony at Brigham Young University were used in DA FSCV studies in vivo. All rats were housed in groups of 2-3 rats per cage in a temperature (21-23°C) and humidity-controlled (55-65 percent) environment on a reverse light/dark cycle with ad libitum food and water. All experimental procedures were approved by the Institutional Animal Care and Use Committees at Daegu Haany University and Brigham Young University.
Drugs and chemicals
(+)Methamphetamine hydrochloride (Sigma, ST. Louis, MO, USA) was dissolved in physiological saline and filtered through a syringe-mounted 0.22-μm Millex-Ha filter unit (Millipore, MO, USA) immediately before selfadministration and IV injection of METH in vivo as previously described (Jang et al. 2015) . The ROS scavengers PBN (a non-specific ROS scavenger; Sigma) and TEMPOL (a superoxide-selective scavenger; Sigma) were dissolved in physiological saline prior to use and administered intraperitoneally (IP) 10 minutes prior to the beginning of self-administration or IV or IP injection of METH. Injection volume of PBN or TEMPOL was 5 ml/kg for all respective doses.
Locomotor activity
Locomotor activity was measured as described previously (Jeon et al. 2008; Zhao et al. 2005) . Locomotor activity was monitored and measured with a video tracking system (Ethovision, Nodus Information Technology BV, Wageningen, Netherlands) that provided automatic measures of traveled distance (meters). Each rat was placed in a square open field box made of black acrylic (40 × 40 × 45 cm) in a dimly lit room. On the test day, rats were habituated for 1 hour in the open field and then basal activity was measured for 30 minutes. After recording basal activity, rats received saline, PBN (75 mg/kg, IP) or TEMPOL (100 mg/kg, IP) 10 minutes prior to saline or METH (1 mg/kg, IP) administration. Locomotor activity was recorded for an additional 1 hour following systemic injection of saline or TEMPOL. Data are expressed as total traveled distance (meters) for 1 hour.
Food training and surgical procedure of catheters Self-administration was carried out in operant chambers (32 × 25 × 34 cm; Med Associates, St. Albans, VT, USA) equipped on one wall with two retractable levers (one active and one inactive lever), a white house light and a stimulus light. To facilitate the acquisition of operant responding in administration chambers, rats were subjected to mild food restriction (approximately 16 g of lab chow a day) and trained to lever-press for 45 mg food pellets (Bio-Serv, Frenchtown, NJ, USSA) on a fixed ratio 1 (FR 1) reinforcement schedule until criterion (100 food pellets for three consecutive days) was achieved in 3-hour daily sessions, as described previously (Jang et al. 2015) . Two days after the last food training, rats were implanted with a chronic catheter in the right jugular vein. The catheter was passed subcutaneously to exit the back of rat through 22-gauge tubing embedded in dental cement and secured with surgical mesh (Ethicon Inc., Somerville, NJ, USA). Following IV catheter surgery, the catheter patency was maintained by a daily flush of 0.2 ml of heparinized saline (30 U/ml), including gentamicin sulfate (0.33 mg/ml), to prevent clotting and infection. Rats were allowed at least 7 days to recover prior to experiments.
Methamphetamine self-administration
To evaluate the effect of PBN and TEMPOL on METH selfadministration, equipment and training procedures were used as previously described (Jang et al. 2015) . After at least 7 days of recovery from IV catheter surgery, the rats began METH self-administration during daily 2-hour FR 1 schedule sessions for 5-6 days/week. To establish a stable baseline, rats were trained to self-administer METH for 2-3 weeks. Levers were allocated as active or inactive. An active lever press delivered a 0.1 ml infusion of METH (0.05 mg/kg) over 5 seconds. METH infusion was paired with illumination of a cue light above the active levers, and the house light was extinguished during infusion of METH. Each infusion was followed by an additional 15-second time-out, while the house light remained off. Lever responses on the active lever during the time-out did not result in METH infusion. We recorded active lever responses and number of METH infusions in this study. Inactive lever press responses were recorded, but had no programmed consequence. Following the establishment of a stable baseline of the METH-reinforced response (three consecutive sessions with less than a 10 percent variation), the rats received IP injections of saline (n = 7-10), PBN (50 mg/kg, n = 5; or 75 mg/kg, n = 5) or TEMPOL (50 mg/kg, n = 6; or 100 mg/kg, n = 7) 10 minutes before beginning METH self-administration. Doses of PBN and TEMPOL were selected based on previous studies (Jang et al. 2015; Kim et al. 2004; Numa et al. 2008) . PBN, TEMPOL and saline were counterbalanced among animals, and the catheters were flushed with 0.2 ml of heparinized saline before and after self-administration.
Food reinstatement
To evaluate the possibility that ROS scavengers, PBN or TEMPOL cause non-specific motor impairment, the responses on each lever were measured in food-trained rats. The rats were food restricted to maintain 85 percent of the initial body weight and trained to lever-press for 45-mg food pellets under an FR 1 with 1 minute timeout during 2-hour daily sessions. After stable lever responding was achieved in three consecutive sessions, rats received saline (n = 7), PBN (75 mg/kg, n = 5) or TEMPOL (100 mg/kg, n = 7) 10 minutes prior to the food reinforcement test. We measured the total number of active and inactive lever responses with food pellets during the 2-hour session.
Immunofluorescence
To measure the level of oxidative stress and the type of ROS-producing cells in the NAc, METH-administering rats were perfused as previously described (Jang et al. 2015) . Briefly, rat brains were removed under isoflurane anesthesia (80 mg/kg, IP), post-fixed with 10 percent sucrose/4 percent paraformaldehyde for 2 hours and cryoprotected in 30 percent sucrose for at least 48 hours. Brains were then cryosectioned into 30-μm slices. Brain tissues were incubated in blocking solution containing 4 percent normal goat serum and 0.1 percent bovine serum albumin at room temperature for 1 hour. After rinsing in 0.01 M PBS, the tissues were incubated with primary antibody for anti-mouse 8-hydroxyguanosine (8-OHG; a cellular marker of oxidative damage; 1:400, Abcam, MA, USA), anti-rabbit GFAP (an astrocyte marker, 1:1000, Millipore, MA, USA), anti-rabbit NeuN (a neuronal marker, 1:1000, Millipore, MA, USA), anti-rabbit Iba-1 (a microglial marker; 1:1000, Wako, Japan) and anti-rabbit NG2 (an oligodendrocyte marker; 1:1000, Chemicon, MA, USA) overnight at 4°C. The sections were then processed with secondary antibodies donkey anti-mouse Alexa Fluor 594 (red; 1:1000) and donkey anti-rabbit Alexa Fluor 488 (green; 1:1000, Invitrogen, Gland Island, NY, USA). All sections were coverslipped with a mounting medium (Vector Laboratories, Burlingame, CA, USA) and were imaged with a 20X objective using a Carl Zeiss AxioCam digital camera attached to the microscope (Carl Zeiss Axioskop, Oberkochen, Germany). The fluorescence intensities of 8-OHG in sections (Area: 30 000 μm 2 ) were estimated by computerized densitometry (ZEN, Oberkochen,Germany).
Fast scan cyclic voltammetry
Electrically evoked DA release in the NAc was measured by FSCV. A 7.0-μm diameter carbon fiber was inserted into borosilicate glass capillary tubing (1.2 mm o.d., A-M Systems, Sequim, WA, USA) under negative pressure and subsequently pulled on a vertical pipette puller (Narishige, East Meadow, NY, USA). The carbon fiber electrode (CFE) was then cut under microscopic control with 150~200 μm of bare fiber protruding from the end of the glass micropipette. The tip of the CFE was dipped in cyanoacrylate, allowed to dry and back-filled with 3 M KCl. The electrode potential was linearly scanned with a triangular waveform from À0.4 to 1.3 V and back to À0.4 V versus Ag/AgCl using a scan rate of 400 V/sec. Cyclic voltammograms were recorded at the CFE every 100 milliseconds (i.e. 10 Hz) by means of a ChemClamp voltage clamp amplifier (Dagan Corporation, Minneapolis, MN, USA). Voltammetry recordings were performed and analyzed using LabVIEW-based (National Instruments, Austin, TX, USA) customized software [Demon Voltammetry (Yorgason et al. 2011)] . For in vivo voltammetry recordings of DA signals, rats were anesthetized with 2 percent isoflurane and placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga, CA, USA). Bipolar, coated stainless steel electrodes were stereotaxically implanted into the medial forebrain bundle (À2.5 mm posterior, +1.9 mm lateral from bregma, À8.0 to À8.3 mm from skull) and a capillary glass-based CFE in the NAc (+1.6 mm anterior, +1.9 mm lateral from bregma, À6.5 to À8.0 mm from skull). The medial forebrain bundle was stimulated with 60 monophasic pulses at 60 Hz (4-millisecond pulse width) at 2-minute intervals. DA levels in the NAc were monitored for a stabilization period typically lasting between 20 minutes and 1 hour. Once the stimulated DA response was stable for four or five successive collections, and did not vary by more than 10 percent, baseline measurements were taken for control and drug treatment. After a stable baseline was established, saline (5 ml/kg) or TEMPOL (100 mg/kg, IP) was injected 10 minutes prior to injection of METH (0.1 mg/kg, IV). DA signals were recorded in 2-minute intervals for 30 minutes post injection. Extracellular concentrations of DA were calibrated by comparing the current at the peak oxidation potential for DA with a known concentration of DA (3 μM). For recordings in live tissue slices, the CFE was positioned~100 μm from a glass stimulating electrode in the NAc core. The core was stimulated with 20 biphasic pulses at 10 Hz (4-millisecond pulse width) at 2-minute intervals. Once the stimulated DA response was stable for four or five successive collections, and did not vary by more than 10 percent, baseline measurements were taken for control and drug treatment. After a stable baseline was established, compounds were bath applied to the tissue.
Preparation of brain slices
Coronal brain slices were prepared as previously described (Steffensen et al. 2008) . Briefly, male mice were anesthetized, decapitated and brains were quickly dissected and sectioned into 400-μm thick coronal slices in ice-cold artificial cerebrospinal fluid (ACSF), bubbled with 95 percent O 2 /5 percent CO 2 . The cutting solution consisted of (in millimolar) 220 Sucrose, 3 KCl, 1.25 NaH 2 PO 4 , 25 NaH 2 CO 3 , 12 MgSO 4 , 10 Glucose and 0.2 CaCl 2 . Slices were immediately placed into an incubation chamber containing normal ACSF bubbled with 95 percent O 2 /5 percent CO 2 at 34-35°C consisting of (in millimolar): 124 NaCl, 2 KCl, 1.25 NaH 2 PO 4 , 24 NaHCO 3 , 12 glucose, 1.2 MgSO 4 , 2 CaCl 2 , pH 7.3. Once slices were transferred to a recording chamber with continuous normal ACSF flow (2.0 ml/min), the temperature was maintained at 36°C throughout the experiment. Slices were allowed to stabilize for an additional 15 minutes before recordings. The striatum was visualized with Nikon Diaphot inverted microscopes in the transmitted light mode, and the NAc core and shell were visualized by microscopic inspection under low magnification at the level of the anterior commissure. A red light filter was placed in the light path to lower the exposure of the slice to short-wavelength light.
Data analysis
Data were analyzed using SPSS STATISTIC 21 (Somers, NY, USA). All data are presented as mean ± SEM (standard error of the mean) and analyzed by one-way repeated measurement analysis of variance, followed by post hoc testing using the Tukey method and Student's t-test, with statistical significance set at (*)P < 0.05, (**)P < 0.01 and (***)P < 0.001. Analysis of DA reuptake kinetics was performed using LabVIEW (National Instruments, Austin, TX)-based customized software (Demon Voltammetry, (Yorgason et al. 2011) ).
RESULTS
Effects of PBN and TEMPOL on methamphetamine-induced locomotor activity
We evaluated the effects of PBN and TEMPOL on METH-induced locomotor activity. After recording basal activity for 30 minutes, rats were administered either IP saline, PBN (75 mg/kg) or TEMPOL (100 mg/kg) 10 minutes prior to systemic injection of saline or METH (1 mg/kg, IP). The dose of METH was selected based on previous studies (Miller et al. 2013; Yun 2014) . A single administration of METH increased locomotor activity (expressed as total distance in meters) compared with the saline-treated group ( Fig. 1b ; Saline 44.40 ± 6.37 m versus METH 197.46 ± 8.09 m, F (1,12) = 4.747, P < 0.001, n = 6-8). Both PBN and TEMPOL significantly attenuated the enhancement of locomotor activity induced by METH (Fig. 1a,b ; F (1,12) = 4.747, P < 0.01 and P < 0.001 versus METH, PBN; 93.53 ± 18.19 m; F (1,14) = 4.600, P < 0.01 and P < 0.05 versus METH, TEMPOL: 137.59 ± 12.50 m, n = 6-8). Neither PBN nor TEMPOL administration alone affected locomotor activity in METH-naïve rats (Fig. 1c, F (2,12) = 2.119, P = 0.153 versus PBN; P = 0.373 versus TEMPOL, n = 5).
Effects of PBN and TEMPOL on methamphetamine self-administration
We evaluated the effects of ROS scavengers, PBN and TEMPOL on METH self-administration. After stable acquisition of METH self-administration, rats were given an IP injection of PBN (0, 50 or 75 mg/kg) 10 minutes prior to the beginning of METH self-administration. Lever presses and the number of METH infusions were monitored for 2 hours following IP injections of saline or PBN (Fig. 2a) . Systemic administration of both 50-and 75 mg/kg PBN significantly decreased infusions of METH in a dose-dependent manner compared with salineinjected controls during the 2-hour test session (Fig. 2b,  c ; 50 mg/kg PBN = 18.0 ± 6.0 responses and 75 mg/kg PBN = 1.0 ± 0.6 responses; F (2,17) = 20.650, P < 0.001; n = 5-10 per group compared with saline = 33 ± 2.8 responses). Additionally, both 50-and 75 mg/kg PBN significantly decreased active lever responses ( Fig. 2d ; 50 mg/kg PBN = 23.0 ± 7.6 responses and 75 mg/kg PBN = 1.0 ± 0.6 responses; F (2,17) = 18.292, P < 0.001 compared with saline = 40.1 ± 3.7 responses). The Figure 1 Effect of PBN and TEMPOL on methamphetamine-induced locomotor activity. After basal activity for 30 minutes, rats were given saline, PBN (75 mg/kg, IP) or TEMPOL (100 mg/kg, intraperitoneally) 10 minutes prior to systemic injection of saline or methamphetamine (METH) (1 mg/kg). (a) Time course of distance traveled (expressed in meters) after systemic injection of saline or METH. (b) Total distance for 1 hour following systemic injection saline or METH. (c) Total distance for 1 hour following PBN or TEMPOL administration alone in METH-naïve rats. Asterisks **,*** represent significance levels P < 0.01 and P < 0.001, respectively, compared with Saline+Saline, and hashtags ##,### represent P < 0.01 and P < 0.001 compared with Saline+METH. Values in parenthesis indicate n values Figure 2 Effect of pretreatment with PBN, a non-specific reactive oxygen species scavenger, on methamphetamine self-administration (METH SA) in rats. Rats were given a non-specific reactive oxygen species scavenger PBN (50 or 75 mg/kg, intraperitoneally) or saline 10 minutes prior to METH SA. 
responses).
To verify the involvement of superoxide, the precursor of most ROS (Turrens 2003) , in mediating METH reinforcement, we performed an experiment similar to PBN, but with the specific superoxide scavenger TEMPOL. Following systemic administration of TEMPOL, 10 minutes prior to METH self-administration, lever presses and the number of METH infusions were monitored for 2 hours following IP injections of saline or TEMPOL (Fig. 3a) . Systemic administration of TEMPOL significantly decreased the number of METH infusions at 100 mg/kg TEMPOL compared with saline-injected controls ( Fig. 3b,c ; 100 mg/kg TEMPOL = 15.6 ± 2.4 responses; F (2,17) = 5.106, P = 0.08; n = 6-7 per group compared with saline = 26.8 ± 3.5 responses. Active lever responding also decreased in a dose-dependent manner ( Fig.  3d ; F (2.17) = 3.829, 50 mg/kg TEMPOL = 30.8 ± 2.9 responses, P = 0.206; 100 mg/kg TEMPOL = 18.0 ± 3.0 responses, P < 0.05 compared with saline 32.4 ± 4.2). TEMPOL, at the 100 mg/kg dose level, significantly decreased active lever pressing. Inactive lever presses were not altered ( Fig. 3e ; 50 mg/kg TEMPOL = 2.2 ± 0.6, P > 0.05 and 100 mg/kg TEMPOL = 1.6 ± 1.6, P > 0.05 compared with saline 1.6 ± 0.7). We also evaluated whether PBN or TEMPOL affects generalized behavioral responses in METH-naïve rats. Neither PBN (75 mg/kg, n = 5) nor TEMPOL (100 mg/kg, n = 7) altered food reinforcement (Fig. 4) , compared with the saline controls (n = 7) (F (2,16) = 2.271, P = 0135). Taken together, these results show that scavenging ROS with PBN or TEMPOL specifically attenuated the reinforcing effects of METH selfadministration without impairment of generalized behavior or food reinforcement.
Oxidative stress in neurons in the nucleus accumbens
To determine ROS production in the NAc following chronic METH self-administration, we performed immunohistochemical experiments with an antibody against 8-OHG, a cellular marker of oxidative stress (Kim et al. 2010; Manczak et al. 2005) . METH self-administering rats showed about a twofold increase in number of 8-OHG positive cells (red signal) as compared with controls ( Fig. 5a-c ; Student's t-test, P = 0.034 versus normal controls, n = 3-4). To further identify the types of cells producing ROS, we performed double immunofluorescence labeling using the following cell-type markers: NeuN (a marker for neurons; green), GFAP (a marker for astrocytes; green), Iba-1 (a marker for microglia; Fig. 5d-f ), but not astrocytes (Fig. 5g-i) , microglia ( Fig. 5j-l) or oligodendrocytes ( Fig. 5m-o) , indicating that increased ROS production in the NAc of rats self-administering METH occurs almost exclusively in neurons.
Effect of TEMPOL on electrically evoked dopamine release
In our previous study, TEMPOL decreased cocaine enhancement of electrically evoked 'phasic' DA release in the NAc (Jang et al. 2015) . We evaluated the effects of TEMPOL (100 mg/kg) on phasic DA release following IV METH injection in the NAc core using FSCV. Intravenous METH administration markedly increased electrically evoked DA release with an EC 50 of 0.1 mg/kg in the NAc core by 200.2 ± 15.7 percent (Fig. 6a,c; F (1,24) = 40.702, P < 0.001, compared with control; n = 13). While 100 mg/kg TEMPOL alone did not significantly alter DA release (P = 0.175 versus baseline controls, data not shown), systemic administration of 100 mg/kg TEMPOL significantly decreased METH enhancement of DA release by 135.8 ± 12.8 percent compared with saline controls (Fig. 6b,d ; F (1.19) = 8.202, P = 0.01, n = 8).
Effects of methamphetamine and TEMPOL on the dopamine transporter
In order to determine if TEMPOL has a direct effect on the DAT, we analyzed DA reuptake kinetics using the time constant of DA reuptake, or tau, from FSCV recordings taken in the slice preparation. TEMPOL (1 mM) had no impact on tau (Fig. 7a,c; F (1,14) = 0.133, P = 0.721) as compared with DA reuptake before TEMPOL superfusion. In contrast, METH (5 μM), which is known to inhibit the DAT, increased tau ( Fig. 7b,c; F (1,20) = 4.998, P = 0.037), which reflects an increased reuptake time. There was no difference in tau between METH (5 μM) versus METH (5 μM) + TEMPOL (1 mM) ( Fig. 7c; F (1,17) = 0.35, P = 0.562).
DISCUSSION
The present study demonstrates that systemic administration of the ROS scavengers PBN and TEMPOL results in (1) a decrease in METH enhancement of locomotor activity without affecting generalized behavior in METHnaïve rats; (2) a decrease in self-administration of METH without affecting food reinforcement; and (3) a decrease in METH-enhanced phasic DA release without affecting the reuptake kinetics mediated by the DAT. In addition, METH increased production of ROS specifically in NAc neurons. Taken together, these findings suggest an important role of ROS in mediating the reinforcing effects of METH in the mesolimbic DA system. Several recent reports have indicated that oxidative stress can modulate the reinforcing effects of drug abuse (Jang et al. 2015; Numa et al. 2008) . Reactive oxygen species are produced through mitochondrial respiration and are critical signaling molecules in cell proliferation and survival. Activation of ROS also leads to oxidative stress via mitochondrial dysfunction, playing a critical role in the progression of a variety of neurodegenerative and psychiatric disorders. Of particular relevance to drug abuse, METH administration is associated with excessive oxidative stress. For example, acute and repeated METH administration causes mitochondrial dysfunction and oxidative stress in rat brains (Beauvais et al. 2011; Horner et al. 2011; Valvassori et al. 2010) . Burrows et al. have shown that proper mitochondrial function was inhibited 23-30 percent by METH in the dorsal striatum and NAc (Burrows et al. 2000) . Additionally, increased oxidative stress markers (lipid and protein oxidation) have been found in the mesocorticolimbic DA system after exposure to METH (Macedo et al. 2010; Shiba et al. 2011) . Increased oxidative stress leads to abnormal behavior including increased locomotor activity (da-Rosa et al. 2012a; da-Rosa et al. 2012b; Gluck et al. 2001; Numa et al. 2008; Shiba et al. 2011 ). We and others have shown that mitochondrial oxidative damage and behavioral changes can be produced by psychostimulants (Jang et al. 2015; Kita et al. 2000; Shiba et al. 2011) . We hypothesize that oxidative stress may, at least in part, modulate the reinforcing properties of METH. In the present Figure 4 Effects of PBN and TEMPOL on food reinforcement in methamphetamine naïve rats. Figure shows total number of responses on active lever (left) and inactive lever (right) during a 2-hour session of food pellet self-administration. When either PBN (75 mg/ kg, intraperitoneally), TEMPOL (100 mg/kg, intraperitoneally) or saline was injected before beginning of food self-administration, there was no significant difference between saline and PBN or TEMPOL groups in total number of responses on active lever and inactive lever during the 2-hour session. 'Food pellets' on the y-axis represents mean number of lever presses for food pellets over 2 hours. Values in parentheses indicate n values study, administration of PBN, a non-specific ROS scavenger, and TEMPOL, a superoxide-specific scavenger, significantly attenuated the reinforcing properties of METH. These results show a crucial role for ROS, especially superoxide, in the positive reinforcing effects of METH. Superoxide (O 2 À ) is a primary ROS formed in cells and is enzymatically converted to hydrogen peroxide (H 2 O 2 ) by SOD, which itself can react with free ions to produce highly reactive and toxic hydroxyl radicals (Fenton reaction).
In the present study, we also evaluated the effects of the SOD-mimetic TEMPOL on METH enhancement of DA release using in vivo FSCV. While METH is known to affect all monoamine systems [i.e. norepinephrine and serotonin (Kogan et al. 1976) ], its reinforcing properties are mediated mostly through the mesocorticolimbic DA (i, l, o) . AC, anterior commissure. n = 3-4 per group. Scale bar = 50 μm system. Methamphetamine increases DA transmission, which is associated with behavioral changes (Akiyama et al. 1994; Hamamura et al. 1991) . Because of its structural similarity to DA, METH can enter the cell through METH (alone or in the presence of TEMPOL) increased the tau compared with controls. TEMPOL alone had no effect on tau and did not alter METH enhancement of tau. Asterisk * represents significance levels P < 0.05 compared with saline. Values in parentheses represent n values DAT, and interacts with VMAT, causing high cytoplasmic levels of DA, which eventually overwhelms the transporter, which is referred to as reverse transport (Cho 1990; Fleckenstein et al. 2007; Kitanaka et al. 2003) . Further, excessive cytoplasmic DA levels contribute to mitochondrial dysfunction and induce oxidative stress via DA auto-oxidation, which produces ROS through the enzymatic degradation of DA. Breakdown of DA produces H 2 O 2 , a precursor to hydroxyl radicals (Graham et al. 1978) , DA-quinone (Miyazaki et al. 2006; Moszczynska et al. 1998) , 6-hydroxydopamine (Maharaj et al. 2005) and also decreases reduced glutathione levels in the brain (Moszczynska et al. 1998) . We found that METHenhanced DA release with an ED 50 of 0.1 mg/kg, which is consistent with the behavioral reinforcing effects (Baracz et al. 2015) . TEMPOL (100 mg/kg) significantly attenuated METH enhancement of DA release in the NAc, suggesting that ROS may contribute to the reinforcing effects of METH by oxidation in the NAc. In a previous study, we determined that the effects of TEMPOL are not related to interactions with the DAT (Jang et al. 2015) , eliminating this potential confounding variable.
Methamphetamine induces unchecked oxidative stress in DA neurons that alters DA release, influencing the reinforcing potential of METH. A possible mechanism for this could be the oxidative stress targeting proteins involved in proper DA uptake and vesicle packaging. We examined the effect of TEMPOL with or without METH ex vivo. While METH dramatically increased DA release in the slice preparation and the time constant tau for DA uptake, TEMPOL did not affect DA uptake. It has been shown that repeated high doses of METH cause a decrease in VMAT2 levels and an increase in S-nitrosylated VMAT2 following METH administration (Eyerman & Yamamoto 2007) . This finding indicates that there are lasting molecular changes due to oxidative stress, particularly superoxide, with high potential to alter proper DA release due to METH. Future studies are needed to confirm this interaction.
Methamphetamine is a particularly addictive substance, which affects both the peripheral and central nervous systems. It acts directly on DAergic neurons, bypassing typical regulation such as GABA circuitry and inhibitory feedback, and causes high levels of DA to be released from DA terminals. Attempting to restore homeostasis, DA systems overcompensate leading to abnormally low DA release during periods of abstinence. This causes a cycle of drug-seeking behavior, as the limbic system learns that the easiest and quickest way to increase DA release is by drug administration. In conclusion, both PBN and TEMPOL attenuated METH-induced locomotor activity without affecting generalized behavior in METH-naïve rats. Both PBN and TEMPOL also attenuated METH self-administration without affecting food intake, and increased oxidative stress was found in NAc neurons of METH self-administering rats. In addition, TEMPOL reduced METH-induced phasic DA transmission in the NAc. Taken together, our findings indicate that increased ROS in the NAc contributes to the reinforcing effects of METH and that ROS scavengers, like TEMPOL, may be effective strategies in reducing the reinforcing properties of METH.
